ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

0R2M Regeneron Pharmaceuticals Inc

296.60
0.00 (0.00%)
May 21 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.86B5.87B6.71B7.86B8.78B16.12B12.26B13.12B
Operating Income 1.33B2.08B2.53B2.21B3.58B8.95B4.74B4.05B
Pre Tax Income 1.33B2.08B2.55B2.43B3.81B9.33B4.86B4.2B
Net Income 895.52M1.2B2.44B2.12B3.51B8.08B4.34B3.95B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 4.1785.32410.7059.49216.24636.75719.58217.951
EBIT 1.34B2.1B2.58B2.34B3.67B9B4.8B4.03B
EBITDA 1.44B2.22B2.68B2.42B3.81B9.23B5.08B4.47B

Your Recent History

Delayed Upgrade Clock